|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0040160,
umls-concept:C0086418,
umls-concept:C0087111,
umls-concept:C0154143,
umls-concept:C0231220,
umls-concept:C0237881,
umls-concept:C0243144,
umls-concept:C0750502,
umls-concept:C1292423,
umls-concept:C1442770,
umls-concept:C1518413,
umls-concept:C1550147,
umls-concept:C1627358,
umls-concept:C2349975
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-8-16
|
|
pubmed:abstractText |
To report the effects of pretreatment with recombinant human thyrotropin (rhTSH) on radioiodine uptake (RAIU) and subsequent radioiodine therapy in 30 patients with symptomatic nontoxic or toxic multinodular goiter.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1530-891X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
253-60
|
|
pubmed:meshHeading |
pubmed-meshheading:15310544-Aged,
pubmed-meshheading:15310544-Aged, 80 and over,
pubmed-meshheading:15310544-Dose-Response Relationship, Radiation,
pubmed-meshheading:15310544-Female,
pubmed-meshheading:15310544-Goiter,
pubmed-meshheading:15310544-Humans,
pubmed-meshheading:15310544-Iodine Radioisotopes,
pubmed-meshheading:15310544-Male,
pubmed-meshheading:15310544-Middle Aged,
pubmed-meshheading:15310544-Radiopharmaceuticals,
pubmed-meshheading:15310544-Thyroid Function Tests,
pubmed-meshheading:15310544-Thyrotropin,
pubmed-meshheading:15310544-Time Factors
|
|
pubmed:articleTitle |
Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter.
|
|
pubmed:affiliation |
Endocrine Associates, PA, Phoenix, Arizona 85013, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
